These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 8768733)

  • 21. Ocular effects of topical administration of the phosphodiesterase III inhibitor milrinone in rabbits and cats.
    Lee KC; Silver PJ; Bode DC; Gherezghiher T
    Methods Find Exp Clin Pharmacol; 1993 Oct; 15(8):527-34. PubMed ID: 8309316
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of nitric oxide synthase inhibitors on the ACTH and cytokine responses to peripheral immune signals.
    Kim CK; Rivier C
    J Neuroendocrinol; 1998 May; 10(5):353-62. PubMed ID: 9663649
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chronic nitric oxide synthase blockade desensitizes the heart to the negative metabolic effects of nitric oxide.
    Davidov T; Weiss HR; Tse J; Scholz PM
    Life Sci; 2006 Sep; 79(17):1674-80. PubMed ID: 16831448
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Specific effects of n-3 fatty acids and 8-bromo-cGMP on the cyclic nucleotide phosphodiesterase activity in neonatal rat cardiac myocytes.
    Picq M; Dubois M; Grynberg A; Lagarde M; Prigent AF
    J Mol Cell Cardiol; 1996 Oct; 28(10):2151-61. PubMed ID: 8930810
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stimulation of renin secretion by nitric oxide is mediated by phosphodiesterase 3.
    Kurtz A; Götz KH; Hamann M; Wagner C
    Proc Natl Acad Sci U S A; 1998 Apr; 95(8):4743-7. PubMed ID: 9539809
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of nitric oxide in the regulation of renin and vasopressin secretion.
    Reid IA
    Front Neuroendocrinol; 1994 Dec; 15(4):351-83. PubMed ID: 7534728
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Species-dependent pharmacodynamic effects of the selective low Km cyclic AMP phosphodiesterase III inhibitors WIN 58993 and WIN 62005.
    Dundore RL; Pagani ED; Bode DC; Bacon ER; Singh B; Lesher GY; Buchholz RA; Silver PJ
    J Cardiovasc Pharmacol; 1995 Jan; 25(1):14-21. PubMed ID: 7723343
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Conditions for augmentation of renin release by theophylline.
    Langård O; Holdaas H; Eide I; Kiil F
    Scand J Clin Lab Invest; 1983 Feb; 43(1):9-14. PubMed ID: 6312554
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nitric oxide regulates peptide release from parasympathetic nerves and vascular reactivity to vasoactive intestinal polypeptide in vivo.
    Modin A; Weitzberg E; Lundberg JM
    Eur J Pharmacol; 1994 Aug; 261(1-2):185-97. PubMed ID: 8001643
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronotropic and inotropic effects of milrinone and congeners: comparison with PDE III inhibition.
    Dorigo P; Floreani M; Belluco P; Gaion RM; Carpenedo F
    Acta Physiol Hung; 1990; 75 Suppl():85-6. PubMed ID: 2371910
    [No Abstract]   [Full Text] [Related]  

  • 31. Neuronal nitric oxide synthase supports Renin release during sodium restriction through inhibition of phosphodiesterase 3.
    Sällström J; Jensen BL; Skøtt O; Gao X; Persson AE
    Am J Hypertens; 2010 Nov; 23(11):1241-6. PubMed ID: 20651700
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Milrinone decreases the positive inotropic response of heart muscle to izadrin].
    Bardamova IB; Afanas'ev SA
    Eksp Klin Farmakol; 1994; 57(4):29-31. PubMed ID: 7950778
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nitric oxide/cAMP interactions in the control of rat renal vascular resistance.
    Sandner P; Kornfeld M; Ruan X; Arendshorst WJ; Kurtz A
    Circ Res; 1999 Feb; 84(2):186-92. PubMed ID: 9933250
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of inhibition of nitric oxide synthesis on vasopressin secretion in conscious rabbits.
    Goyer M; Bui H; Chou L; Evans J; Keil LC; Reid IA
    Am J Physiol; 1994 Feb; 266(2 Pt 2):H822-8. PubMed ID: 7511350
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of inhibition of nitric oxide synthesis on the cardiovascular and endocrine responses to hemorrhage in conscious rabbits.
    Chiu T; Reid IA
    Hypertens Res; 1995 Mar; 18(1):55-61. PubMed ID: 7584911
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-platelet action of nitric oxide and selective phosphodiesterase inhibitors.
    Sly MK; Eberhart RC; Prager MD
    Shock; 1997 Aug; 8(2):115-8. PubMed ID: 9261901
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of blockade of nitric oxide synthesis on the renin secretory response to frusemide in conscious rabbits.
    Reid IA; Chou L
    Clin Sci (Lond); 1995 Jun; 88(6):657-63. PubMed ID: 7543396
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanisms of desensitization to a PDE inhibitor (milrinone) in conscious dogs with heart failure.
    Sato N; Asai K; Okumura S; Takagi G; Shannon RP; Fujita-Yamaguchi Y; Ishikawa Y; Vatner SF; Vatner DE
    Am J Physiol; 1999 May; 276(5):H1699-705. PubMed ID: 10330256
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacological characterization of a new milrinone analogue.
    Dorigo P; Fraccarollo D; Santostasi G; Gaion RM; Maragno I; Floreani M; Carpenedo F; Jester M; Mosti L; Schenone P
    Farmaco; 1994 Jan; 49(1):19-23. PubMed ID: 8185745
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of calcium in the interaction of alpha and beta adrenoceptor-mediated renin release in isolated, constant pressure perfused rabbit kidneys.
    Opgenorth TJ; Zehr JE
    J Pharmacol Exp Ther; 1983 Oct; 227(1):144-9. PubMed ID: 6312014
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.